INJECTIONS of reovirus, a harmless virus that infects most people at some point but rarely causes symptoms, appears to boost the action of cancer drugs.
At a meeting last week of the in San Diego, California, of Calgary in Alberta, Canada, reported positive results from two trials of its drug Reolysin, which contains reovirus. In one, at the Royal Marsden Hospital in London, nine patients were given Reolysin plus the standard anti-cancer drugs paclitaxel and carboplatin. Cancers stopped growing in four people and shrank in another four, staying that way…
